Clinical TrialsSearch results
Number of results: 1090
Recruiting
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
- Atherosclerotic Cardiovascular Disease (ASCVD) Elevated Lp(a)
- Masaki Takeshi
- 2024-03-15
Recruiting
- A study to investigate the safety and efficacy of belantamab for the treatment of multiple myeloma when used as monotherapy and in combination treatments
- Multiple Myeloma
- Ishibashi Hideyasu
- 2023-07-07
Recruiting
- A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
- HR-positive, HER2-negative Advanced or Metastatic Breast Cancer
- Kawai Norisuke
- 2024-03-11
Recruiting
- A Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety and Tolerability of Zerlasiran in Japanese Subjects With Elevated Serum Lipoprotein(a)
- Japanese subjects with elevated Lp(a)
- Fok Henry
- 2024-06-18
Recruiting
- Accuracy of coronary MR plaque imaging in patient with chronic kidney disease associated with coronary artery disease
- coronary artery disease, ischemic stroke, hypertension, peripheral arterial disease, diabetes mellit
- Noguchi Teruo
- 2021-09-05
Recruiting
- ACQUAINT-trial
- Heart failure
- Izumi Chisato
- 2020-10-09
Recruiting
- Additional synbiotics to combination therapy with immune checkpoint inhibitors for unresectable or recurrent gastric and esophageal cancer
- Gastric cancer , esophageal cancer
- Kurokawa Yukinori
- 2023-07-04
Recruiting
- AJI-2022VLIT-S1
- Health Conditions
- Miura Naoki
- 2023-11-25
Recruiting
- An early phase II study of RBM-007 in children with achondroplasia
- Achondroplasia
- Nonaka Yosuke
- 2022-08-26
Recruiting
- An Expanded Access Program of CNT-01 in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy
- Idiopathic triglyceride deposit cardiomyovasculopathy
- Akita Yasuhiko
- 2023-01-30